Application of a high-density microelectrode array assay using a 3D human iPSC-derived brain microphysiological system model for in vitro neurotoxicity screening of environmental compounds

Unraveling the associations between human exposure to environmental chemicals and potential neurotoxicity presents significant challenges. Evaluation of neurotoxicity potential using animal testing is resource-intensive (financial, labor, and animal use) and faces uncertainties regarding biological...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of toxicology Jg. 99; H. 7; S. 2917 - 2935
Hauptverfasser: Carstens, Kelly E., Gronskaya, Elena, Jäckel, David, Bertoli, Jessica, Cuevas, Kelvin Ramirez, Dorier, Julien, Wang, Shan, Lopez-Rodriguez, David, Shafer, Timothy J., Zurich, Marie-Gabrielle, Pamies, David
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Berlin/Heidelberg Springer Berlin Heidelberg 01.07.2025
Springer Nature B.V
Schlagworte:
ISSN:0340-5761, 1432-0738, 1432-0738
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Unraveling the associations between human exposure to environmental chemicals and potential neurotoxicity presents significant challenges. Evaluation of neurotoxicity potential using animal testing is resource-intensive (financial, labor, and animal use) and faces uncertainties regarding biological relevance to human health outcomes. Therefore, there is a need to develop efficient and human-relevant in vitro new approach methodologies (NAMs) to screen and evaluate chemicals for neurotoxicity potential. Recording of neural network activity using microelectrode array (MEA) technology has been identified as a reliable and reproducible method for evaluating neurotoxicity. Much of this research has been performed in 2D rodent-derived cell models. The ‘BrainSpheres MEA assay’ described in this study offers a promising functional human induced pluripotent stem cell (iPSC)-derived 3D brain model comprising neurons, astrocytes, and oligodendrocytes. We demonstrate consistent spontaneous neuronal firing and network bursting parameters from 7-week-old BrainSpheres using a high-density MEA technology. The performance of this model as a human-relevant NAM was evaluated by conducting a multi-concentration, 13 day exposure study with a set of ten chemicals. Neural activity metrics were assessed and compared to results from a 2D-MEA assay using rodent cells. Loperamide and domoic acid (two assay positive controls) demonstrated similar bioactivity profiles in the BrainSphere MEA assay to the 2D-MEA assay, while acetaminophen (assay negative control) was inactive in both assays. The 2D-MEA model demonstrated more potent bioactivity for 4/7 chemicals that were active in both assays. In the future, reducing replicate variability and testing a larger set of chemicals will likely improve the accuracy and reliability of the assay. These preliminary findings suggest that the BrainSphere assay could be used alongside the rat network formation assay (rNFA) as part of a tiered strategy, where hits in the rNFA are confirmed and further characterized in the BrainSphere model, helping move toward animal-free toxicological testing.
AbstractList Unraveling the associations between human exposure to environmental chemicals and potential neurotoxicity presents significant challenges. Evaluation of neurotoxicity potential using animal testing is resource-intensive (financial, labor, and animal use) and faces uncertainties regarding biological relevance to human health outcomes. Therefore, there is a need to develop efficient and human-relevant in vitro new approach methodologies (NAMs) to screen and evaluate chemicals for neurotoxicity potential. Recording of neural network activity using microelectrode array (MEA) technology has been identified as a reliable and reproducible method for evaluating neurotoxicity. Much of this research has been performed in 2D rodent-derived cell models. The ‘BrainSpheres MEA assay’ described in this study offers a promising functional human induced pluripotent stem cell (iPSC)-derived 3D brain model comprising neurons, astrocytes, and oligodendrocytes. We demonstrate consistent spontaneous neuronal firing and network bursting parameters from 7-week-old BrainSpheres using a high-density MEA technology. The performance of this model as a human-relevant NAM was evaluated by conducting a multi-concentration, 13 day exposure study with a set of ten chemicals. Neural activity metrics were assessed and compared to results from a 2D-MEA assay using rodent cells. Loperamide and domoic acid (two assay positive controls) demonstrated similar bioactivity profiles in the BrainSphere MEA assay to the 2D-MEA assay, while acetaminophen (assay negative control) was inactive in both assays. The 2D-MEA model demonstrated more potent bioactivity for 4/7 chemicals that were active in both assays. In the future, reducing replicate variability and testing a larger set of chemicals will likely improve the accuracy and reliability of the assay. These preliminary findings suggest that the BrainSphere assay could be used alongside the rat network formation assay (rNFA) as part of a tiered strategy, where hits in the rNFA are confirmed and further characterized in the BrainSphere model, helping move toward animal-free toxicological testing.
Unraveling the associations between human exposure to environmental chemicals and potential neurotoxicity presents significant challenges. Evaluation of neurotoxicity potential using animal testing is resource-intensive (financial, labor, and animal use) and faces uncertainties regarding biological relevance to human health outcomes. Therefore, there is a need to develop efficient and human-relevant in vitro new approach methodologies (NAMs) to screen and evaluate chemicals for neurotoxicity potential. Recording of neural network activity using microelectrode array (MEA) technology has been identified as a reliable and reproducible method for evaluating neurotoxicity. Much of this research has been performed in 2D rodent-derived cell models. The 'BrainSpheres MEA assay' described in this study offers a promising functional human induced pluripotent stem cell (iPSC)-derived 3D brain model comprising neurons, astrocytes, and oligodendrocytes. We demonstrate consistent spontaneous neuronal firing and network bursting parameters from 7-week-old BrainSpheres using a high-density MEA technology. The performance of this model as a human-relevant NAM was evaluated by conducting a multi-concentration, 13 day exposure study with a set of ten chemicals. Neural activity metrics were assessed and compared to results from a 2D-MEA assay using rodent cells. Loperamide and domoic acid (two assay positive controls) demonstrated similar bioactivity profiles in the BrainSphere MEA assay to the 2D-MEA assay, while acetaminophen (assay negative control) was inactive in both assays. The 2D-MEA model demonstrated more potent bioactivity for 4/7 chemicals that were active in both assays. In the future, reducing replicate variability and testing a larger set of chemicals will likely improve the accuracy and reliability of the assay. These preliminary findings suggest that the BrainSphere assay could be used alongside the rat network formation assay (rNFA) as part of a tiered strategy, where hits in the rNFA are confirmed and further characterized in the BrainSphere model, helping move toward animal-free toxicological testing.Unraveling the associations between human exposure to environmental chemicals and potential neurotoxicity presents significant challenges. Evaluation of neurotoxicity potential using animal testing is resource-intensive (financial, labor, and animal use) and faces uncertainties regarding biological relevance to human health outcomes. Therefore, there is a need to develop efficient and human-relevant in vitro new approach methodologies (NAMs) to screen and evaluate chemicals for neurotoxicity potential. Recording of neural network activity using microelectrode array (MEA) technology has been identified as a reliable and reproducible method for evaluating neurotoxicity. Much of this research has been performed in 2D rodent-derived cell models. The 'BrainSpheres MEA assay' described in this study offers a promising functional human induced pluripotent stem cell (iPSC)-derived 3D brain model comprising neurons, astrocytes, and oligodendrocytes. We demonstrate consistent spontaneous neuronal firing and network bursting parameters from 7-week-old BrainSpheres using a high-density MEA technology. The performance of this model as a human-relevant NAM was evaluated by conducting a multi-concentration, 13 day exposure study with a set of ten chemicals. Neural activity metrics were assessed and compared to results from a 2D-MEA assay using rodent cells. Loperamide and domoic acid (two assay positive controls) demonstrated similar bioactivity profiles in the BrainSphere MEA assay to the 2D-MEA assay, while acetaminophen (assay negative control) was inactive in both assays. The 2D-MEA model demonstrated more potent bioactivity for 4/7 chemicals that were active in both assays. In the future, reducing replicate variability and testing a larger set of chemicals will likely improve the accuracy and reliability of the assay. These preliminary findings suggest that the BrainSphere assay could be used alongside the rat network formation assay (rNFA) as part of a tiered strategy, where hits in the rNFA are confirmed and further characterized in the BrainSphere model, helping move toward animal-free toxicological testing.
Author Carstens, Kelly E.
Zurich, Marie-Gabrielle
Cuevas, Kelvin Ramirez
Pamies, David
Jäckel, David
Lopez-Rodriguez, David
Shafer, Timothy J.
Gronskaya, Elena
Bertoli, Jessica
Dorier, Julien
Wang, Shan
Author_xml – sequence: 1
  givenname: Kelly E.
  surname: Carstens
  fullname: Carstens, Kelly E.
  organization: Center for Computational Toxicology and Exposure, USA Environmental Protection Agency
– sequence: 2
  givenname: Elena
  surname: Gronskaya
  fullname: Gronskaya, Elena
  organization: MaxWell Biosystems AG
– sequence: 3
  givenname: David
  surname: Jäckel
  fullname: Jäckel, David
  organization: MaxWell Biosystems AG
– sequence: 4
  givenname: Jessica
  surname: Bertoli
  fullname: Bertoli, Jessica
  organization: Department of Biomedical Sciences, University of Lausanne
– sequence: 5
  givenname: Kelvin Ramirez
  surname: Cuevas
  fullname: Cuevas, Kelvin Ramirez
  organization: Department of Biomedical Sciences, University of Lausanne
– sequence: 6
  givenname: Julien
  surname: Dorier
  fullname: Dorier, Julien
  organization: Bioinformatics Competence Center, University of Lausanne, Bioinformatics Competence Center, Ecole Polytechnique Fédérale de Lausanne
– sequence: 7
  givenname: Shan
  surname: Wang
  fullname: Wang, Shan
  organization: Department of Biomedical Sciences, University of Lausanne
– sequence: 8
  givenname: David
  surname: Lopez-Rodriguez
  fullname: Lopez-Rodriguez, David
  organization: Department of Biomedical Sciences, University of Lausanne, Swiss Centre for Applied Human Toxicology (SCAHT), Institute of Earth Surface Dynamics, University of Lausanne
– sequence: 9
  givenname: Timothy J.
  surname: Shafer
  fullname: Shafer, Timothy J.
  organization: Center for Computational Toxicology and Exposure, USA Environmental Protection Agency
– sequence: 10
  givenname: Marie-Gabrielle
  surname: Zurich
  fullname: Zurich, Marie-Gabrielle
  organization: Department of Biomedical Sciences, University of Lausanne, Swiss Centre for Applied Human Toxicology (SCAHT)
– sequence: 11
  givenname: David
  orcidid: 0000-0002-1224-573X
  surname: Pamies
  fullname: Pamies, David
  email: David.pamies@unil.ch
  organization: Department of Biomedical Sciences, University of Lausanne, Swiss Centre for Applied Human Toxicology (SCAHT), Stem Cells and Organoid Facility, University of Lausanne
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40293475$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1vEzEQhleoiKaFP8ABWeLCZWH8kez6hKpAAakSSMDZcryziatde7F3o-S_8eM6aVo-eujFPvh533k9M2fFSYgBi-Ilh7ccoHqXAQSoEsS8BAVKlrsnxYwrKUqoZH1SzEAqKOfVgp8WZzlfA3BRa_msOFUgtFTVfFb8vhiGzjs7-hhYbJllG7_elA2G7Mc9671LETt0Y4oNMpuS3TObM51T9mFNvPzANlNvA_Pfvi9JmPwWG7ZK1oejfNjss49dXFOZjuV9HrFnPdl1rI2JEbb1ZM8CTimOcefdoXJ2CTEcSlAqDFufYugxjGThYj_EKTT5efG0tV3GF3f3efHz8uOP5efy6uunL8uLq9KpqhpLx8FaFK7RjWgRV0JpJXhTtZa6CJxbV2u9aACF1KJu5wslqD_tClGBttrK8-L90XeYVj02jmIk25kh-d6mvYnWm_9fgt-YddwaLriuRS3I4c2dQ4q_Jsyj6X122HU2YJyykVzPa-D1QhH6-gF6HacU6H9GCqEAas45Ua_-jfQny_1kCaiPAE0g54StobbejpkS-s5wMIclMsclMrRE5naJzI6k4oH03v1RkTyKMsFhjelv7EdUN64K370
CitedBy_id crossref_primary_10_1016_j_pbiomolbio_2025_07_005
Cites_doi 10.1007/978-3-030-11135-9_12
10.1039/c5lc00133a
10.1557/s43577-022-00282-w
10.14573/altex.1712081
10.1002/jnr.10367
10.14573/altex.1609122
10.1016/j.tox.2024.153842
10.14573/altex.1604201
10.1016/j.neuro.2007.06.004
10.1177/1087057114532352
10.3390/biology10020086
10.22427/NICEATM-2
10.1016/j.taap.2004.05.003
10.1016/j.neuro.2016.03.019
10.1007/s00204-019-02636-x
10.1002/jnr.10508
10.1016/j.neuro.2010.10.007
10.3390/ijms22179473
10.1016/j.tiv.2022.105333
10.1093/toxsci/kfac018
10.3389/ftox.2023.1275980
10.1093/toxsci/kfab008
10.1038/nature12517
10.1016/j.ntt.2022.107117
10.1093/bioinformatics/btab779
10.1016/j.reprotox.2020.08.002
10.1093/toxsci/kfz052
10.1016/j.taap.2018.02.003
10.2741/2758
10.1038/mp.2011.13
10.1038/s41598-018-38130-0
10.1016/j.toxlet.2022.07.757
10.1093/toxsci/kfw147
10.1016/j.neuro.2018.06.007
10.1016/j.neuro.2012.05.001
10.1016/j.tifs.2023.02.006
10.1007/s00204-017-2035-5
10.1186/s13024-018-0258-4
10.1289/ehp.0800168
10.1016/j.nbd.2022.105719
10.1002/cpz1.158
10.1089/ten.TEC.2015.0375
10.1016/j.celrep.2014.12.051
10.1039/b907394a
10.1111/j.1741-4520.2012.00374.x
10.1016/j.biomaterials.2013.11.028
10.3389/fneng.2011.00004
10.1016/j.amjmed.2023.03.033
10.1258/jrsm.2007.070164
10.1016/j.neuro.2010.04.001
10.1093/toxsci/kfx169
10.1007/978-1-60761-984-0_1
10.14573/altex.2206031
10.1109/BioCAS.2014.6981723
10.1523/ENEURO.0308-23.2023
10.1038/nprot.2014.020
10.1016/j.aogh.2016.01.005
10.3390/cells12091270
10.1038/s41467-022-32115-4
10.1016/j.stem.2016.07.005
10.3389/fncel.2020.00025
10.1038/s41928-023-01069-w
10.1038/nmeth.3415
10.1038/nature13716
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
Copyright Springer Nature B.V. Jul 2025
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: Copyright Springer Nature B.V. Jul 2025
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T2
7TK
7U7
C1K
K9.
7X8
5PM
DOI 10.1007/s00204-025-04043-x
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Health and Safety Science Abstracts (Full archive)
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef

ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1432-0738
EndPage 2935
ExternalDocumentID PMC12198282
40293475
10_1007_s00204_025_04043_x
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: Novartis
  funderid: http://dx.doi.org/10.13039/100004336
– fundername: Swiss Centre for Applied Human Toxicology
  grantid: AP20-4
  funderid: http://dx.doi.org/10.13039/501100011039
– fundername: University of Lausanne
– fundername: Swiss Centre for Applied Human Toxicology
  grantid: AP20-4
GroupedDBID ---
-Y2
.55
.86
.GJ
.HR
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
23N
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
4.4
406
408
409
40D
40E
4P2
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
7XC
88E
88I
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACZOJ
ADBBV
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFGCZ
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ATCPS
ATHPR
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DWQXO
EBD
EBLON
EBS
EDH
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GQ8
GUQSH
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2O
M2P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PATMY
PF0
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
PYCSY
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSU
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
ZGI
ZMTXR
ZOVNA
~EX
~KM
AAYXX
ABRTQ
AFFHD
BANNL
CITATION
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7T2
7TK
7U7
C1K
K9.
7X8
5PM
ID FETCH-LOGICAL-c477t-c10aae2cd9d2feeb249421d7fa007011ac8996d0e23928f5642029fbee409a9a3
IEDL.DBID RSV
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001489883500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0340-5761
1432-0738
IngestDate Tue Nov 04 02:05:13 EST 2025
Fri Sep 05 17:22:41 EDT 2025
Thu Nov 06 14:29:53 EST 2025
Sun Jun 29 01:31:19 EDT 2025
Tue Nov 18 22:00:53 EST 2025
Sat Nov 29 07:51:03 EST 2025
Thu Jun 26 01:51:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords MPS
3D cultures
Neurotoxicology
iPSC
MEA
High-density electrode array
Microelectrode array
BrainSphere
Neuronal electrical activity
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-c10aae2cd9d2feeb249421d7fa007011ac8996d0e23928f5642029fbee409a9a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1224-573X
OpenAccessLink https://link.springer.com/10.1007/s00204-025-04043-x
PMID 40293475
PQID 3224008111
PQPubID 60277
PageCount 19
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12198282
proquest_miscellaneous_3195801864
proquest_journals_3224008111
pubmed_primary_40293475
crossref_citationtrail_10_1007_s00204_025_04043_x
crossref_primary_10_1007_s00204_025_04043_x
springer_journals_10_1007_s00204_025_04043_x
PublicationCentury 2000
PublicationDate 2025-07-01
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Archives of toxicology
PublicationTitleAbbrev Arch Toxicol
PublicationTitleAlternate Arch Toxicol
PublicationYear 2025
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References PJ Landrigan (4043_CR68) 2016; 82
RJ McMurtrey (4043_CR37) 2016; 22
MG Zurich (4043_CR67) 2004; 201
AFM Johnstone (4043_CR29) 2010; 31
J Hartmann (4043_CR24) 2023
M Feshuk (4043_CR21) 2023; 5
ER McConnell (4043_CR36) 2012; 33
R Tsuji (4043_CR59) 2012; 52
X Zhong (4043_CR65) 2020; 14
D Pamies (4043_CR46) 2018; 354
ZX Wen (4043_CR63) 2014; 515
K Muguruma (4043_CR38) 2015; 10
MA Lancaster (4043_CR32) 2013; 501
HT Hogberg (4043_CR26) 2011; 32
AM Pasca (4043_CR49) 2015; 12
T Sheffield (4043_CR56) 2022; 38
EY Adashi (4043_CR1) 2023; 136
LS Gerber (4043_CR23) 2021; 1
T Takebe (4043_CR58) 2014; 9
L Berdondini (4043_CR5) 2009; 9
KM Crofton (4043_CR17) 2011; 28
4043_CR43
E van Vliet (4043_CR60) 2007; 28
TJ Shafer (4043_CR53) 2019; 22
MB Kosnik (4043_CR31) 2020; 94
CL Frank (4043_CR22) 2017; 160
C Nunes (4043_CR42) 2022
NRC (4043_CR41) 2007
D Pamies (4043_CR47) 2022; 169
JP Brown (4043_CR8) 2016; 154
J Jo (4043_CR28) 2016; 19
RA Matthews (4043_CR35) 2008; 101
MG Zurich (4043_CR66) 2002; 70
M Chesnut (4043_CR14) 2021
D Pamies (4043_CR44) 2017; 34
MM Martin (4043_CR33) 2022; 93
S Plummer (4043_CR50) 2019; 9
MM Martin (4043_CR34) 2024; 505
M Aschner (4043_CR2) 2017; 34
R Judson (4043_CR30) 2009; 117
J Muller (4043_CR39) 2015; 15
M Paparella (4043_CR48) 2020; 96
AM Tukker (4043_CR71) 2016; 33
JD Strickland (4043_CR57) 2018; 92
M Sachana (4043_CR51) 2021
JW Haycock (4043_CR25) 2011; 695
TJ Shafer (4043_CR54) 2019; 169
C Eskes (4043_CR19) 2003; 71
I Cattaneo (4043_CR12) 2023; 133
A Bal-Price (4043_CR3) 2018; 35
H Cai (4043_CR9) 2023; 6
D Zhang (4043_CR64) 2014; 35
KE Carstens (4043_CR10) 2022; 187
D Pamies (4043_CR45) 2018; 354
L Saavedra (4043_CR70) 2021; 180
EGZ Centeno (4043_CR13) 2018; 13
I Cattaneo (4043_CR11) 2022; 368
LG Costa (4043_CR16) 2008; 13
A Vassallo (4043_CR61) 2017; 60
M Schröter (4043_CR52) 2022; 47
T Sharf (4043_CR55) 2022; 13
4043_CR20
A Walzl (4043_CR62) 2014; 19
CH Chiang (4043_CR15) 2011; 16
A Novellino (4043_CR40) 2011; 4
K Bartmann (4043_CR4) 2023; 40
4043_CR7
4043_CR6
4043_CR27
MAT Elliott (4043_CR18) 2023
AM Tukker (4043_CR72) 2018; 67
References_xml – volume: 22
  start-page: 275
  year: 2019
  ident: 4043_CR53
  publication-title: Adv Neurobiol
  doi: 10.1007/978-3-030-11135-9_12
– volume: 15
  start-page: 2767
  issue: 13
  year: 2015
  ident: 4043_CR39
  publication-title: Lab Chip
  doi: 10.1039/c5lc00133a
– volume: 47
  start-page: 530
  issue: 6
  year: 2022
  ident: 4043_CR52
  publication-title: MRS Bull
  doi: 10.1557/s43577-022-00282-w
– volume: 35
  start-page: 306
  issue: 3
  year: 2018
  ident: 4043_CR3
  publication-title: Altex
  doi: 10.14573/altex.1712081
– volume: 70
  start-page: 108
  issue: 1
  year: 2002
  ident: 4043_CR66
  publication-title: J Neurosci Res
  doi: 10.1002/jnr.10367
– volume: 34
  start-page: 362
  issue: 3
  year: 2017
  ident: 4043_CR44
  publication-title: Altex
  doi: 10.14573/altex.1609122
– volume: 505
  year: 2024
  ident: 4043_CR34
  publication-title: Toxicology
  doi: 10.1016/j.tox.2024.153842
– volume: 34
  start-page: 49
  issue: 1
  year: 2017
  ident: 4043_CR2
  publication-title: Altex
  doi: 10.14573/altex.1604201
– volume: 28
  start-page: 1136
  issue: 6
  year: 2007
  ident: 4043_CR60
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2007.06.004
– volume: 19
  start-page: 1047
  issue: 7
  year: 2014
  ident: 4043_CR62
  publication-title: J Biomol Screen
  doi: 10.1177/1087057114532352
– year: 2021
  ident: 4043_CR51
  publication-title: Biology (Basel)
  doi: 10.3390/biology10020086
– ident: 4043_CR27
  doi: 10.22427/NICEATM-2
– volume: 201
  start-page: 97
  issue: 2
  year: 2004
  ident: 4043_CR67
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2004.05.003
– volume: 60
  start-page: 280
  year: 2017
  ident: 4043_CR61
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2016.03.019
– volume-title: Toxicity testing in the twenty-first century: a vision and a strategy
  year: 2007
  ident: 4043_CR41
– volume: 94
  start-page: 469
  issue: 2
  year: 2020
  ident: 4043_CR31
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-019-02636-x
– volume: 71
  start-page: 583
  issue: 4
  year: 2003
  ident: 4043_CR19
  publication-title: J Neurosci Res
  doi: 10.1002/jnr.10508
– volume: 32
  start-page: 158
  issue: 1
  year: 2011
  ident: 4043_CR26
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2010.10.007
– year: 2021
  ident: 4043_CR14
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22179473
– year: 2022
  ident: 4043_CR42
  publication-title: Toxicol in Vitro
  doi: 10.1016/j.tiv.2022.105333
– volume: 187
  start-page: 62
  issue: 1
  year: 2022
  ident: 4043_CR10
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfac018
– volume: 5
  start-page: 1275980
  year: 2023
  ident: 4043_CR21
  publication-title: Front Toxicol
  doi: 10.3389/ftox.2023.1275980
– volume: 180
  start-page: 295
  issue: 2
  year: 2021
  ident: 4043_CR70
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfab008
– volume: 501
  start-page: 373
  issue: 7467
  year: 2013
  ident: 4043_CR32
  publication-title: Nature
  doi: 10.1038/nature12517
– volume: 93
  year: 2022
  ident: 4043_CR33
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/j.ntt.2022.107117
– volume: 38
  start-page: 1157
  issue: 4
  year: 2022
  ident: 4043_CR56
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btab779
– volume: 96
  start-page: 327
  year: 2020
  ident: 4043_CR48
  publication-title: Reprod Toxicol (Elmsford, NY)
  doi: 10.1016/j.reprotox.2020.08.002
– volume: 169
  start-page: 436
  issue: 2
  year: 2019
  ident: 4043_CR54
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfz052
– volume: 354
  start-page: 101
  year: 2018
  ident: 4043_CR45
  publication-title: Toxicol Appl Pharm
  doi: 10.1016/j.taap.2018.02.003
– ident: 4043_CR20
– volume: 13
  start-page: 1240
  year: 2008
  ident: 4043_CR16
  publication-title: Front Biosci
  doi: 10.2741/2758
– volume: 16
  start-page: 358
  issue: 4
  year: 2011
  ident: 4043_CR15
  publication-title: Mol Psychiatr
  doi: 10.1038/mp.2011.13
– volume: 9
  start-page: 1407
  year: 2019
  ident: 4043_CR50
  publication-title: Sci Rep-Uk
  doi: 10.1038/s41598-018-38130-0
– volume: 368
  start-page: S288
  year: 2022
  ident: 4043_CR11
  publication-title: Toxicol Lett
  doi: 10.1016/j.toxlet.2022.07.757
– volume: 154
  start-page: 126
  issue: 1
  year: 2016
  ident: 4043_CR8
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfw147
– volume: 67
  start-page: 215
  year: 2018
  ident: 4043_CR72
  publication-title: Neurotoxicol
  doi: 10.1016/j.neuro.2018.06.007
– volume: 33
  start-page: 1048
  issue: 5
  year: 2012
  ident: 4043_CR36
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2012.05.001
– volume: 133
  start-page: 277
  year: 2023
  ident: 4043_CR12
  publication-title: Trends Food Sci Tech
  doi: 10.1016/j.tifs.2023.02.006
– volume: 92
  start-page: 487
  issue: 1
  year: 2018
  ident: 4043_CR57
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-017-2035-5
– volume: 13
  start-page: 27
  issue: 1
  year: 2018
  ident: 4043_CR13
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-018-0258-4
– volume: 117
  start-page: 685
  issue: 5
  year: 2009
  ident: 4043_CR30
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.0800168
– volume: 169
  year: 2022
  ident: 4043_CR47
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2022.105719
– volume: 1
  issue: 6
  year: 2021
  ident: 4043_CR23
  publication-title: Curr Protoc
  doi: 10.1002/cpz1.158
– volume: 22
  start-page: 221
  issue: 3
  year: 2016
  ident: 4043_CR37
  publication-title: Tissue Eng Part C Methods
  doi: 10.1089/ten.TEC.2015.0375
– volume: 354
  start-page: 101
  year: 2018
  ident: 4043_CR46
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2018.02.003
– volume: 10
  start-page: 537
  issue: 4
  year: 2015
  ident: 4043_CR38
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.12.051
– volume: 9
  start-page: 2644
  issue: 18
  year: 2009
  ident: 4043_CR5
  publication-title: Lab Chip
  doi: 10.1039/b907394a
– volume: 52
  start-page: 122
  issue: 3
  year: 2012
  ident: 4043_CR59
  publication-title: Congenit Anom (Kyoto)
  doi: 10.1111/j.1741-4520.2012.00374.x
– volume: 35
  start-page: 1420
  issue: 5
  year: 2014
  ident: 4043_CR64
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.11.028
– volume: 28
  start-page: 9
  issue: 1
  year: 2011
  ident: 4043_CR17
  publication-title: Altex
– volume: 4
  start-page: 4
  year: 2011
  ident: 4043_CR40
  publication-title: Front Neuroeng
  doi: 10.3389/fneng.2011.00004
– ident: 4043_CR7
– volume: 136
  start-page: 853
  issue: 9
  year: 2023
  ident: 4043_CR1
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2023.03.033
– volume: 101
  start-page: 95
  issue: 2
  year: 2008
  ident: 4043_CR35
  publication-title: J R Soc Med
  doi: 10.1258/jrsm.2007.070164
– volume: 31
  start-page: 331
  issue: 4
  year: 2010
  ident: 4043_CR29
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2010.04.001
– volume: 160
  start-page: 121
  issue: 1
  year: 2017
  ident: 4043_CR22
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfx169
– volume: 695
  start-page: 1
  year: 2011
  ident: 4043_CR25
  publication-title: Methods Mol Biol (Clifton, NJ)
  doi: 10.1007/978-1-60761-984-0_1
– volume: 33
  start-page: 261
  issue: 3
  year: 2016
  ident: 4043_CR71
  publication-title: ALTEX
– volume: 40
  start-page: 452
  issue: 3
  year: 2023
  ident: 4043_CR4
  publication-title: Altex
  doi: 10.14573/altex.2206031
– ident: 4043_CR6
  doi: 10.1109/BioCAS.2014.6981723
– year: 2023
  ident: 4043_CR18
  publication-title: eNeuro
  doi: 10.1523/ENEURO.0308-23.2023
– volume: 9
  start-page: 396
  issue: 2
  year: 2014
  ident: 4043_CR58
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2014.020
– volume: 82
  start-page: 10
  issue: 1
  year: 2016
  ident: 4043_CR68
  publication-title: Ann Glob Health
  doi: 10.1016/j.aogh.2016.01.005
– year: 2023
  ident: 4043_CR24
  publication-title: Cells
  doi: 10.3390/cells12091270
– volume: 13
  start-page: 4403
  issue: 1
  year: 2022
  ident: 4043_CR55
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-32115-4
– volume: 19
  start-page: 248
  issue: 2
  year: 2016
  ident: 4043_CR28
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2016.07.005
– volume: 14
  start-page: 25
  year: 2020
  ident: 4043_CR65
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2020.00025
– volume: 6
  start-page: 1032
  issue: 12
  year: 2023
  ident: 4043_CR9
  publication-title: Nature Electronics
  doi: 10.1038/s41928-023-01069-w
– volume: 12
  start-page: 671
  issue: 7
  year: 2015
  ident: 4043_CR49
  publication-title: Nat Methods
  doi: 10.1038/nmeth.3415
– volume: 515
  start-page: 414
  issue: 7527
  year: 2014
  ident: 4043_CR63
  publication-title: Nature
  doi: 10.1038/nature13716
– ident: 4043_CR43
SSID ssj0012893
Score 2.45522
Snippet Unraveling the associations between human exposure to environmental chemicals and potential neurotoxicity presents significant challenges. Evaluation of...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2917
SubjectTerms Acetaminophen
Animal models
Animal research
Arrays
Assaying
Astrocytes
Astrocytes - drug effects
Biological activity
Biomedical and Life Sciences
Biomedicine
Brain
Brain - cytology
Brain - drug effects
Cell culture
Cells, Cultured
Chemical activity
Chemicals
Cosmetics
Domoic acid
Electrodes
Environmental Health
Environmental Pollutants - toxicity
High density
Humans
In vitro methods and tests
In Vitro Systems
Induced Pluripotent Stem Cells - drug effects
Microelectrodes
Microphysiological Systems
Morphology
Network formation
Neural networks
Neurons - drug effects
Neurotoxicity
Neurotoxicity Syndromes - etiology
Occupational Medicine/Industrial Medicine
Oligodendrocytes
Oligodendroglia - drug effects
Pharmacology/Toxicology
Pluripotency
Reproducibility
Rodents
Stem cells
Toxicity
Toxicity Tests - methods
Title Application of a high-density microelectrode array assay using a 3D human iPSC-derived brain microphysiological system model for in vitro neurotoxicity screening of environmental compounds
URI https://link.springer.com/article/10.1007/s00204-025-04043-x
https://www.ncbi.nlm.nih.gov/pubmed/40293475
https://www.proquest.com/docview/3224008111
https://www.proquest.com/docview/3195801864
https://pubmed.ncbi.nlm.nih.gov/PMC12198282
Volume 99
WOSCitedRecordID wos001489883500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: Springer LINK
  customDbUrl:
  eissn: 1432-0738
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0012893
  issn: 0340-5761
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB61tIdKiD6BAEWu1FtrKc6G2D4iKOJQIVRatLfIcew2UsmibEDw3_hxzDgPutBWai-RooztRB7PIzPzDcD7zBXKoFnLM20tTzNDZw5vhVOZd9r7OFR4n36WR0dqOtXHfVHYfMh2H0KSQVKPxW6hjpNT-9WYIGE4Wo5PUN0pOo5fTk7H2AG6EF1T5DTmaE2LvlTm93MsqqMHNubDVMl78dKghg6e_98HvICV3uxkux2fvIRHrn4Fy90_O9aVIr2Gm927aDabeWYYgRnzknLc22t2Rrl7fduc0jHTNOaaoe2NV8qe_470k30Wmv6x6vhkDwc2KEtLVlAbim54-JEyyFvWwUiz0I2HofXMkOyywulZgNlsZ1eVpZVRtKG7TUvgW_1SmodTUEo8dYaav4FvB5--7h3yvrsDt6mULbciNsYlttRl4h06-KlOE1FKbwiCSAhj0RXMytglaMIpv4OOUpxoXziHLqnRZrIKS_WsduvATOaFEVK6Ar1JI7TyLtGE_I7WjSxsEYEYNjm3PfQ5deD4mY-gzWFvctybPOxNfhXBh3HMeQf88VfqrYF38l4IzPNJSNBVqE0ieDc-xuNLMRlTu9kF0hDYTyxUlkaw1rHauBy69nqSyp0I1AITjgQEDb74pK5-BIhwgYoIfekkgo8DL969158_Y-PfyDfhWRLYmbKXt2CpbS7cW3hqL9tq3mzDYzlV2-Fs3gJgOjgq
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB6kCgri3RqtOoJvupDNSZPsY-mFisdDsbX0LWw2uzbQ5khOWtr_5o9zZnOpx6qgL4GQ2d2EmZ2dycx8A_A2sUWmyawViTJGxInmPUe30maJs8q50Fd4H07T2Sw7OlJ7fVHYYsh2H0KSXlOPxW6-jlNw-9WQIWEEWY43YzqxOJHv8_7hGDsgF6JrihyHgqxp2ZfK_H6O5ePomo15PVXyl3ipP4Z27v_fBzyAe73ZiRudnDyEG7Z-BHe7f3bYlSI9hu8bV9FsnDvUyGDGouQc9_YSTzl3r2-bU1rUTaMvkWxvunL2_Fein2yhb_qH1d7-Jg1sSJeWWHAbim64_5Ey6FvsYKTRd-NBsp6RyM4rmh49zGY7v6gMr0yqjdxtXoLe6qfSPJqCU-K5M9TiCXzZ2T7Y3BV9dwdh4jRthZGh1jYypSojZ8nBjxVxs0ydZggiKbUhVzApQxuRCZe5dXKUwki5wlpySbXSk6ewUs9r-wxQJ05qmaa2IG9SS5U5GylGfifrJi1MEYAcmJybHvqcO3Cc5CNos-dNTrzJPW_yiwDejWO-dcAff6VeG2Qn75XAIp_4BN2MTpMA3oyPaftyTEbXdn5GNAz2E8osiQNY7URtXI5cezWJ0_UAsiUhHAkYGnz5SV0de4hwSQcR-dJRAO8HWbx6rz9_xvN_I38Nt3cPPk3z6YfZxxdwJ_KizZnMa7DSNmf2Jdwy5221aF75HfoDrOU6Jg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ha9UwED9kigjDOXWzbroM_KZhTV_XNh_H5kNxPB5sjn0raZpsBe0bfd3Y_jf_OO-StttzKohfCqWXpCWX5K539_sBvEtMkSk0a3kiteZxomjN4a0wWWKNtDZ0Fd4nh-lkkp2eyumdKn6X7d6HJH1NA6E01e3ORWl3hsI3V9PJiYo1JHgYjlbkw5hIg8hfPzoZ4gjoTniC5DjkaFmLrmzm930sHk337M37aZO_xE7dkTRe-f-PeQZPO3OU7Xn9WYUHpn4Oy_5fHvMlSi_gx95tlJvNLFOMQI55Sbnv7Q37Tjl9HZ1OaZhqGnXD0CbHK2XVn6H86IA5MkBWTY_2sWGDe2zJCqKn8M3dD5Z-H2YeXpo5lh6GVjVDsasKu2cOfrOdXVeaRsYtD91wGgLf6k7JHnZBqfLEGDV_CV_HH4_3P_GO9YHrOE1brkWolIl0KcvIGnT8YxlHokytImgiIZRGFzEpQxOhaZfZXXSgwkjawhh0VZVUozVYqme1eQVMJVYokaamQC9TCZlZE0lChEerJy10EYDoJzzXHSQ6MXN8ywcwZzc3Oc5N7uYmvw7g_dDmwgOC_FV6s9ejvNsc5vnIJe5meMoEsD08xmVNsRpVm9klyhAIUCiyJA5g3avdMBy6_HIUp7sBZAsKOQgQZPjik7o6d9DhAg8o9LGjAD70enn7Xn_-jNf_Jr4Fj6cH4_zw8-TLBjyJnGZTgvMmLLXNpXkDj_RVW82bt26x_gS_QkMK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Application+of+a+high-density+microelectrode+array+assay+using+a+3D+human+iPSC-derived+brain+microphysiological+system+model+for+in+vitro+neurotoxicity+screening+of+environmental+compounds&rft.jtitle=Archives+of+toxicology&rft.au=Carstens%2C+Kelly+E.&rft.au=Gronskaya%2C+Elena&rft.au=J%C3%A4ckel%2C+David&rft.au=Bertoli%2C+Jessica&rft.date=2025-07-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0340-5761&rft.eissn=1432-0738&rft.volume=99&rft.issue=7&rft.spage=2917&rft.epage=2935&rft_id=info:doi/10.1007%2Fs00204-025-04043-x&rft_id=info%3Apmid%2F40293475&rft.externalDocID=PMC12198282
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5761&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5761&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5761&client=summon